We are live on ! Find out more
VI

Vestcor Inc Portfolio holdings

AUM $3.63B
1-Year Est. Return 21.49%
This Fund
S&P 500
This Quarter Est. Return
+1.29%
1 Year Est. Return
+21.49%
3 Year Est. Return
+77.59%
5 Year Est. Return
+109.03%
10 Year Est. Return
–
AUM
$3.63B
AUM Growth
+$123M
Cap. Flow
+$186M
Cap. Flow %
5.11%
Top 10 Hldgs %
18.05%
Holding
1,319
New
163
Increased
386
Reduced
255
Closed
127

Top Buys

Rank Stock Value
1
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$52.5M
2
DUK icon
Duke Energy
DUK
+$11.9M
3
CTSH icon
Cognizant
CTSH
+$10.8M
4
O icon
Realty Income
O
+$9.5M
5
COR icon
Cencora
COR
+$8.86M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$18.5M
2
USMV icon
iShares MSCI USA Min Vol Factor ETF
USMV
+$17.2M
3
RNAM
Avidity Biosciences
RNAM
+$14.4M
4
EXAS
Exact Sciences
EXAS
+$14.2M
5
EEMV icon
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
+$9.45M

Sector Composition

Rank Sector Weight
1 Technology 22.97%
2 Healthcare 10.61%
3 Financials 9.99%
4 Real Estate 9.52%
5 Communication Services 9.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CADE
1201
DELISTED
Cadence Bank
CADE
– –
-60,000
Closed -$2.57M
CAKE icon
1202
Cheesecake Factory
CAKE
$4.21B
– –
-8,043
Closed -$406K
CALX icon
1203
Calix
CALX
$2.27B
– –
-1,932
Closed -$102K
CARG icon
1204
CarGurus
CARG
$3.01B
– –
-5,565
Closed -$213K
CARS icon
1205
Cars.com
CARS
$641M
– –
-2,248
Closed -$27K
CBZ icon
1206
CBIZ
CBZ
$2.29B
– –
-971
Closed -$49K
CCRN
1207
DELISTED
Cross Country Healthcare
CCRN
$0 ﹤0.01%
12
-2,398
-100% -$21.5K
CDTX
1208
DELISTED
Cidara Therapeutics
CDTX
– –
-25,000
Closed -$5.52M
CENTA icon
1209
Central Garden & Pet Co Class A
CENTA
$2.41B
– –
-7,036
Closed -$205K
CFLT
1210
DELISTED
Confluent
CFLT
– –
-219,319
Closed -$6.63M
CHEF icon
1211
Chefs' Warehouse
CHEF
$3.87B
– –
-980
Closed -$61K
CHRD icon
1212
Chord Energy
CHRD
$7.79B
– –
-4,228
Closed -$392K
CIVI
1213
DELISTED
Civitas Resources
CIVI
– –
-26,394
Closed -$715K
CLBT icon
1214
Cellebrite
CLBT
$3.54B
– –
-3,783
Closed -$68K
CMA
1215
DELISTED
Comerica
CMA
– –
-80,000
Closed -$6.95M
CNYA icon
1216
iShares MSCI China A ETF
CNYA
$221M
– –
-7,644
Closed -$264K
CORT icon
1217
Corcept Therapeutics
CORT
$10.2B
– –
-4
Closed –
CRC icon
1218
California Resources
CRC
$4.75B
– –
-3,313
Closed -$148K
CREVW
1219
DELISTED
Carbon Revolution PLC Warrant
CREVW
– –
-33,333
Closed –
CYBR
1220
DELISTED
CyberArk
CYBR
– –
-2,134
Closed -$952K
DAVEW icon
1221
Dave Inc Warrants
DAVEW
$34.3M
$0 ﹤0.01%
125
– –
DFIN icon
1222
Donnelley Financial Solutions
DFIN
$1.21B
– –
-3,105
Closed -$145K
DGII icon
1223
Digi International
DGII
$2.52B
– –
-3,731
Closed -$162K
DOO
1224
Bombardier Recreational Products
DOO
$4.43B
– –
-22,490
Closed -$1.59M
DORM icon
1225
Dorman Products
DORM
$4.01B
– –
-2,726
Closed -$336K
47 48
49
50 51

Similar funds

JFG
JMG Financial Group Downers Grove, Illinois $3.63B AUM 17.91% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
ACM
Advent Capital Management New York $3.63B AUM 0.29% 1-Year Est. Return
APP
Avantax Planning Partners Dubuque, Iowa $3.64B AUM 14.73% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
OCM
One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $3.61B AUM 24.09% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Vestcor Inc's Q1 2026 Portfolio in Review

As of Q1 2026, Vestcor Inc held 1,319 positions worth $3.63B, up 3.5% from $3.51B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Vestcor Inc deployed $186M of net new capital in Q1 2026, opening 163 new positions and adding to 386 existing holdings. Its largest new stake was Revolution Medicines: 63,077 shares worth $6.13M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $18.5M trimmed.

  • Vestcor Inc's largest Q1 2026 buy was Revolution Medicines: 63,077 shares worth $6.13M.
  • Vestcor Inc added most to iShares Core MSCI Emerging Markets ETF in Q1 2026, an estimated $52.5M increase.
  • Vestcor Inc's biggest Q1 2026 reduction was Bristol-Myers Squibb, cutting an estimated $18.5M.
  • Vestcor Inc fully exited Avidity Biosciences in Q1 2026, selling an estimated $14.4M.
  • Vestcor Inc's ten largest holdings make up 18% of its $3.63B portfolio in Q1 2026.
  • Vestcor Inc opened 163 new positions and closed 127 in Q1 2026.
  • Vestcor Inc's portfolio value rose 3.5% quarter-over-quarter to $3.63B.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.